Q3 2018 Holdings
Filed 2018-11-14 | 46 holdings | $366.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $139.1M | 1,963,336 | 38.0% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $132.7M | 1,368,103 | 36.2% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $57.3M | 755,415 | 15.6% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common | 14888U101 | $17.0M | 4,497,042 | 4.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $16.3M | 849,899 | 4.4% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $2.1M | 100,000 | 0.6% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $369.0K | 17,714,461 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $226.0K | 4,798,101 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $152.4K | 943,500 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $112.8K | 9,333,132 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $99.1K | 463,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $97.5K | 8,662,720 | 0.0% |
| Endocyte Inc | Common | 29269A102 | $94.2K | 5,301,718 | 0.0% |
| Horizon Pharma PLC | Common | G4617B105 | $87.3K | 4,460,426 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $72.3K | 1,457,913 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $65.8K | 4,045,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $54.1K | 1,771,500 | 0.0% |
| Puma Biotechnology Inc(PBYI) | Common | 74587V107 | $52.8K | 1,150,685 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $38.9K | 1,048,427 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | Common | 189464100 | $33.7K | 1,146,636 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $32.1K | 684,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $31.2K | 2,367,218 | 0.0% |
| TG Therapeutics Inc(TGTX) | Common | 88322Q108 | $23.5K | 4,200,031 | 0.0% |
| Teligent Inc | Common | 87960W104 | $20.9K | 5,299,431 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $20.3K | 413,196 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $15.2K | 5,437,779 | 0.0% |
| Sesen BIO Inc | Common | 817763105 | $14.6K | 6,800,000 | 0.0% |
| Intec Pharma LTD | Common | M53644106 | $14.5K | 2,570,705 | 0.0% |
| Establishment Labs Holdings Inc(ESTA) | Common | G31249108 | $11.4K | 475,000 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $10.9K | 287,500 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $9.9K | 430,000 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | Common | 00444P108 | $8.6K | 280,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $8.4K | 1,022,666 | 0.0% |
| Y Mabs Therapeutics Inc(YMABUSD) | Common | 984241109 | $8.2K | 310,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | Common | H17182108 | $6.5K | 147,368 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $6.1K | 6,241,581 | 0.0% |
| Tesaro Inc | Common | 881569107 | $5.9K | 150,000 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $2.6K | $6,000,000 | 0.0% |
| Principia Biopharma Inc(PRNB) | Common | 74257L108 | $2.2K | 75,000 | 0.0% |
| DBV Technologies SA | Sponsored ADR | 23306J101 | $1.2K | 54,000 | 0.0% |
| Spdr Series Trust - S&P Biotech(XBI)Put | ETF | 78464A870 | $1.2K | 1,500,000 | 0.0% |
| Oncosec Medical Inc | Common | 68234L207 | $700 | 500,000 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $670 | 683,531 | 0.0% |
| Invesco QQQ Trust(QQQ)Put | ETF | 46090E103 | $175 | 500,000 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $3 | 233,333 | 0.0% |